A new study finds that biologic therapies significantly reduce the risk of heart attacks and strokes in patients with psoriasis or psoriatic arthritis. Learn more about the cardiovascular benefits of ...
Delays in diagnosing and treating psoriatic arthritis – a common inflammatory disorder affecting 112 in every 100,000 adults – are causing irreparable ...
While pharmacologic therapies remain central to managing PsO and PsA, non-pharmacologic interventions also play a crucial ...
21h
Delays in diagnosing and treating psoriatic arthritis—a common inflammatory disorder affecting around 200,000 people in the U ...
Janus kinase (JAK) inhibitors, including ruxolitinib cream and abrocitinib, demonstrate strong efficacy in atopic dermatitis ...
Posters presented at the 2025 American Academy of Dermatology Annual Meeting found tildrakizumab outcomes to have a mean drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback